Showing 1561-1570 of 3038 results for "".
- The Vision Council Opens Registration for 2026 Executive Summithttps://modernod.com/news/the-vision-council-opens-registration-for-2026-executive-summit/2484153/The Vision Council announced that registration is open for the 2026 Executive Summit. The 3-day forum will be held January 26-28, 2026, at The Ritz-Carlton, Amelia Island, Florida.
- Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposiumhttps://modernod.com/news/abstract-on-zeta-1-study-of-apx3330-receives-award-at-women-in-ophthalmology-wio-summer-symposium/2481795/Ocuphire Pharma announced that data from its phase 2 clinical trial of APX3330 in diabetic retinopathy (DR) were featured in an oral presentation on Saturday, August 26 at the
- Eyenovia Announces Poster Presentation at ASCRS 2022https://modernod.com/news/eyenovia-announces-poster-presentation-at-ascrs-2022/2480776/Eyenovia announced that the company will present an ePoster at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, which is being held April 23-26 in Washington, D.C. Details of the ePoster presentation are as follows: <
- Graybug to Present at the 2022 ASCRS Annual Meetinghttps://modernod.com/news/graybug-to-present-at-the-2022-ascrs-annual-meeting/2480770/Graybug Vision announced a platform presentation at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, to be held in Washington, D.C. from April 22-26, 2022. Information is listed below and available on the
- China Gives Green Light to Allergan’s Xen Registration for the Surgical Management of Refractory Glaucomahttps://modernod.com/news/china-gives-green-light-to-allergans-xen-registration-for-the-surgical-management-of-refractory-glaucoma/2477514/Allergan announced China’s National Medical Products Administration (NMPA) approved the registration of Allergan’s Xen Gel Stent on March 26, 2020 for the surgical management of patients with refractory glaucoma. Xen is th
- Allergan to Present New Data on Investigational Medicines at AAOhttps://modernod.com/news/allergan-to-present-new-data-on-investigational-medicines-at-aao/2479768/Allergan will present new data at the annual meeting of the American College of Ophthalmology (AAO) to be held in Chicago. The Retina Subspecialty Day (October 26-27) will feature two late-breaker presentations on the
- ImprimisRx to Feature New Formulation and Poster Presentation on MKO Melt at AAO Meeting in Chicagohttps://modernod.com/news/imprimisrx-to-feature-new-formulation-and-poster-presentation-on-mko-melt-at-aao-meeting-in-chicago/2479781/ImprimisRx announced its participation at the upcoming 2018 American Academy of Ophthalmology (AAO) annual meeting to be held at the McCormick Place Convention Center in Chicago, October 26-30. At the conference, attendees will have the opportunity to meet with ImprimisRx representatives
- At-Home App Helps Patients Stay Engaged and Adherent to Vision Monitoring Remotelyhttps://modernod.com/news/at-home-app-helps-patients-stay-engaged-and-adherent-to-vision-monitoring-remotely/2479208/Novartis announced it has begun a US pilot program for OdySight, a clinically tested mobile application designed to help monitor vision remotely. Recent changes to public health protocols, paired with a growing patient population and existing treatment burden, have placed an emphasis on vi
- Tilak Healthcare Launches US Pilot for OdySight Medical Vision Monitoring Apphttps://modernod.com/news/tilak-healthcare-launches-us-pilot-for-odysight-medical-vision-monitoring-app/2479202/Tilak Healthcare is launching a pilot program in the US with Novartis for OdySight, Tilak’s first clinically tested mobile app for patient remote vision monitoring. The program is the first to launch under an international collaboration announced in 2020 between Tilak Healthcare and
- Vision Advocates Rally to Defend National Eye Institute from Funding Cuts and Consolidation Threatshttps://modernod.com/news/vision-advocates-rally-to-defend-national-eye-institute-from-funding-cuts-and-consolidation-threats/2482913/Vision science and eye care organizations are mobilizing efforts to combat proposals circulating in Washington to slash federal vision funding and consolidate the National Eye Institute (NEI) into a broader institute on brain and dental research.